Psychedelic News

Post-traumatic stress Disorder (PTSD) is a debilitating mental health condition that affects millions of people worldwide. It affects 5% of the US population, and viable treatment options are lacking. MDMA-assisted therapy offers a new glimmer of hope for people suffering from the aftereffects of trauma. The Multidisciplinary Association for Psychedelic Studies PBC, or MAPS, has…

In November 2022, Lusaris Therapeutics made news for its $60 million Series A round. Since then, there has been a curious silence from the company. We recently came across a rumor that the company was shutting down. After a month of attempting to confirm this, we have come up empty-handed. That within itself is strange…

Legal psychedelics are closer than ever to becoming a reality in California. Senator Scott Weiner has been trying to push a psychedelic bill through the California legislature for several years now, and the end is now within sight.  Weiner’s initial bill was unsuccessful. However, his second try has now made it to the governor’s desk….

Many experts have been predicting some big mergers and acquisitions in the psychedelic industry. Well, it looks like they were spot on.  This week has brought with it announcements of the two biggest acquisitions in the history of this emerging industry. On Monday, Cybin announced that it would be acquiring Small Pharma. Both are clinical-stage…